Navigation Links
EntreMed Raises $20 Million to Support Clinical Development Program
Date:9/17/2007

Secured Financing Led by GE Healthcare Financial Services

ROCKVILLE, Md., Sept. 17 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that it has completed a $20 million secured loan agreement with a syndicate of lenders led by GE Healthcare Financial Services, and participated by Merrill Lynch Capital, a division of Merrill Lynch Business Financial Services Inc., and Oxford Finance Corporation. The full amount of the $20 million loan, less fees, was funded at closing.

James S. Burns, EntreMed President and Chief Executive Officer, commented on the financing, "This transaction provides EntreMed with a non-dilutive financing vehicle that strengthens our cash position and will fund anticipated clinical development expenses into 2009. The loan collateral includes EntreMed's interest in royalty revenues on sales of Celgene's Thalomid(R). We have been funded by three leading commercial finance organizations that specialize in life science companies, and I am grateful for their confidence in EntreMed."

Mr. Burns further commented, "Proceeds from this transaction will be used primarily to support development costs for our ongoing clinical studies with Panzem(R) NCD, MKC-1, and ENMD-1198, and to fund IND-directed activities for Panzem(R) in rheumatoid arthritis and our Aurora-angiogenesis inhibitor in oncology."

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company developing therapeutic candidates primarily for the treatment of cancer and inflammation. Panzem(R) NCD (2-methoxyestradiol or 2ME2) is currently in multiple Phase 2 clini
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Clinical Results From EntreMeds Panzem NCD and Taxol Breast Cancer Study Presented at ASCO
2. Phase 2 Results for EntreMeds Panzem NCD Brain Cancer Study Presented at ASCO
3. EntreMeds Aurora Kinase Inhibitor Induces Tumor Regression in Preclinical Models
4. EntreMed Presents Preclinical Data for MKC-1 in Hematological Cancers
5. EntreMed Presents Multi-Mechanism Results for ENMD-1198 at AACR Annual Meeting
6. EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in Preclinical Models
7. EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds
8. Major Discovery Raises Prospect of Better Patient Care By Improving Platelet Life Span
9. Pelosi: Bush Veto of Stem Cell Bill Says No to the Hopes of Million of Families Across America
10. Trichomoniasis: Most Common Curable STD in U.S. Affects 7.4 Million Annually
11. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... SHENZHEN, China   , July 2, 2015 ... sequencing laboratory in Hong Kong ... (CAP). The BGI Hong Kong facility is the first clinical ... China , meeting the highest standard in ... 21 CFR Part 11 compliant laboratory process, and multiple ...
(Date:7/2/2015)... , July 2, 2015   Wilson Therapeutics AB ... of Hans Schikan to its board of directors. The ... General Meeting on June 30. "We are ... said Jonas Hansson , CEO of Wilson Therapeutics. ... and we look forward to his contributions to the ...
(Date:7/1/2015)... SCHAUMBURG, Ill. , July 1, 2015 /PRNewswire-USNewswire/ ... a nationwide group of state and regional professional ... national survey of rheumatologists that explored perceptions of ... drugs on patients. Biosimilars are ... to biologic medicines. They are notably different from ...
Breaking Medicine Technology:BGI Receives Accreditation from the College of American Pathologists (CAP) 2Wilson Therapeutics Appoints Hans Schikan to its Board of Directors 2Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards 2
(Date:7/2/2015)... Washington, D.C. (PRWEB) , ... July 02, 2015 , ... ... kicking off the 2015 swim season with important lessons on how to stay water ... Polar Bear Who Couldn’t, Wouldn’t Swim, authored by The ZAC Foundation co-founders, follows Zeke’s ...
(Date:7/2/2015)... , ... July 02, 2015 ... ... janitorial supply company , announced today that it has reached an ... acquisition will make CleanItSupply.com the largest distributor of Rubbermaid Commercial Products on ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ... Research (CVR) recently received nearly $4 million through five federal grants to ... vaccines and therapies against the deadly diseases. , The research will be ...
(Date:7/2/2015)... ... July 02, 2015 , ... B. E. Smith, the only ... lead a national chief operating officer recruitment for Nicklaus Children’s Hospital ... industry, B. E. Smith has recently placed more than 1,000 healthcare executives into ...
(Date:7/2/2015)... CA (PRWEB) , ... July 02, 2015 , ... ... mission driven Nutraceutical company, is announcing with their launch an intention to partner ... safe holistic health solutions on the planet. Their innovative water soluble, Cannabidiol (CBD) ...
Breaking Medicine News(10 mins):Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 3Health News:CleanItSupply.com Acquires eRubbermaid.com 2Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 2Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 4Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 2Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 3Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 2Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 3
... the Bill & Melinda Gates Foundation announced it would ... support vaccine research, development and delivery throughout the developing ... as pneumonia, diarrhea and malaria take the lives of ... countries, simply because life-saving vaccines don,t reach those who ...
... January 29 2010- Project A.L.S. (New York, NY) and ... Hopkins University (Baltimore, MD) announced that they will partner ... advance ALS (Lou Gehrig,s disease) research exponentially over the ... Packard Center, non-profit leaders in forging productive collaborations among ...
... Grail" in medical imaging has been the development of an ... intervene early in diseases and rapidly determine the effectiveness of ... Notre Dame and the Washington University School of Medicine describes ... and dying cells in mammary and prostate tumors in living ...
... area of genital tract, study finds , FRIDAY, Jan. 29 ... genital tract, a finding that may help improve treatment and ... collected daily samples from seven separate genital sites in four ... was detected on more than one area on 56 percent ...
... on why listening to music seems so beneficial, , FRIDAY, ... is long: It can soothe infants and adults alike, trigger ... faster or slower. "It," of course, is music. ... suggestions for years. Just why music seems to have these ...
... , DALLAS , Jan. 29 ... from across the nation will be participants in its Medical Transportation ... has increased its giving by 23 percent in 2010, the program,s ... in transportation to 29 medical organizations who then provide tickets ...
Cached Medicine News:Health News:Project A.L.S. and Packard Center take aim at ALS with $15 million program 2Health News:New paper describes important advance in imaging of cell death 2Health News:Tune Up Your Health 2Health News:Tune Up Your Health 3Health News:Southwest Airlines Announces Recipients of its 2010 Medical Transportation Grant Program 2
Stryker Endoscopy offers a superior selection of probes and tips that interface with our suction and irrigation system....
... Tear Pool punctum plugs. Tear Pool punctum plugs ... with no additives via a precision molding process. ... which is designed to facilitate insertion as well ... position in the punctum. The cap of the ...
... BIOTRONIK AG will be the world wide ... stent. Radically different from conventional drug eluting ... first non-surface-coated drug eluting stent designed to ... proprietary technologies allow release profiles to be ...
... Technologies has developed the first intra-operative ... surgeons to confirm the location of ... graft functionality during coronary artery bypass ... enables the surgeon to view, record, ...
Medicine Products: